Table 5.
Summary of adverse effects
| Adverse effect |
Treatment Group
*
|
||
|---|---|---|---|
| TAC | 5FU | T+F | |
| Telangiectasia | 3 | 0 | 1 |
| Skin atrophy | 4 | 0 | 2 |
| Skin ulceration | 0 | 9 | 4 |
| Systemic adverse effects | 0 | 0 | 0 |
*
Values denote number of patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.